Ranbaxy looks to rebuild its US business
After facing massive losses coupled with regulatory hurdles in the American market, Ranbaxy Laboratories Ltd has chalked out plans to revamp its US business.
After facing massive losses coupled with regulatory hurdles in the American market, Ranbaxy Laboratories Ltd has chalked out plans to revamp its US business.
GE Healthcare, the $17-billion healthcare arm of General Electric launched new, low cost products, aimed at developing markets such as India, as the company seeks to spend around $6 billion on its global strategy to grow its revenues from emerging markets.
Ahmedabad-based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of INR 100 crore from the sale of its patented combination drug, Policap, which it expects to launch by the middle of next month.
Aquilonis, a mobile software products and solutions company located in Bangalore, India and Boston, Massachusetts, USA has announced a strategic team alliance and partnership with Clinical Solutions International (CSI), LLC to make their mobile communications solutions available to the medical device community.
Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of changing trends in the key market.
V Raja, President & CEO (South Asia), GE Healthcare talks with eHEALTH about achievements and initiatives of his company in India, and challenges that are holding back the real success of domestic manufacturing in this country.
Modern electronics is revolutionising healthcare like never before. While bringing superior diagnostic and therapeutic capabilities, electronic and semiconductor technologies are also making healthcare ever more efficient, accessible and affordable.
Popularly known for its unprecedented leadership in consumer electronics segment, Sony also offers a wide range of products for high definition medical imaging, recording, storage, viewing and printing solutions.
Cadila, one of India’s most well-known pharmaceutical companies, has decided to deploy TAKE Solutions’ PharmaReady eCTD, SPL and PPM software.
Ranbaxy Laboratories announced that its new anti-malarial combination drug is now undergoing final stage of development. In its press-release, the company said that the drug is targeted at patients in developing countries with the aim of significantly improving upon the conventional options available for the treatment of P falciparum malaria.
Established in 1991 in Shenzen, China, Mindray Medical has since emerged as one of the leading global manufacturer and supplier of […]
eHealth caught up with Anjan Bose, Senior Director and Business Head, Philips Healthcare, to get his perspective on the needs of […]
Modern electronics is revolutionising healthcare like never before. While bringing superior diagnostic and therapeutic capabilities, electronic and semiconductor technologies are also making […]